Ulcerative colitis Trials in Marietta, United States
Conditions / Ulcerative colitis / Marietta, United States
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02100696 | A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors | COMPLETED | PHASE3 |
| NCT02435992 | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT02914535 | Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06975722 | A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis | RECRUITING | — |
| NCT02118584 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | TERMINATED | PHASE3 |
| NCT03759041 | A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis | TERMINATED | PHASE2 |
| NCT02914522 | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01465763 | A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00073021 | Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00505778 | A Comparison of Once a Day Dose Compared to 2 Doses/Day | COMPLETED | PHASE3 |